South Korea’s position in the global clinical trial rankings may be climbing and the proportion of such studies taking place in the country for the development of global new drugs rising. But compared to other major markets, it still takes longer to launch novel products locally following their first global launch, a new study shows.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?